Vericel® Corporation · 4 hours ago
Quality Inspector I
Cambridge, MA
Full-time
Onsite
New Grad, Entry Level
$20.16/hr - $25.28/hr
0+ years expVericel Corporation is a pioneer in advanced cell therapies for sports medicine and severe burn care, dedicated to transforming patient lives through innovative treatments. The Quality Inspector I will be responsible for raw material sampling and inspection, overseeing laboratory inventory, and supporting Quality Control operations across multiple facilities.
BiotechnologyLife ScienceTherapeutics
Responsibilities
Perform inspection, sampling, testing, and disposition of components and raw materials as per SOP's and specifications
Collaborate regularly with R&D, QA and Materials Management
Partner with outside vendors to coordinate offsite QC operations
Support of Quality Control operations by performing basic laboratory responsibilities including environmental monitoring, lab support, inventory of laboratory chemicals and critical reagent supplies, and sample submissions to contract labs
Create, revise, issue material specifications
Individual will facilitate and monitor the material lifecycle process
Flexible and responsive to customer needs
Other responsibilities as required
Qualification
Required
HS Diploma, 0-1 years' industry experience in cGMP, or equivalent
Direct work experience in raw materials quality inspection system and related systems
Effective time management, multitasking and organizational skills
Strong attention to detail and cross functional team experience
Must be able to lift/pull up to 40 pounds
Personal transportation required
Occasional Weekend or Holiday coverage (as needed)
Rotating off-shift alarm coverage. May be required to carry a company issued cell phone
Preferred
Direct technical experience writing CAPA's
Computer skills in systems such as Microsoft Word, Excel and TrackWise
Knowledge of Laboratory Information Management Systems (LIMS)
Benefits
Bonus
Incentive pay
Equity
Benefits
Company
Vericel® Corporation
Vericel is a leading provider of advanced therapies for the sports medicine and severe burn care markets.
201-500 employees
Funding
Current Stage
Public CompanyTotal Funding
$157.3MKey Investors
Eastern Capital
2018-06-07Post Ipo Equity· $74.8M
2016-12-16Post Ipo Equity· $20M
2012-03-09Post Ipo Equity· $40M
Leadership Team
J
Jonathan Siegal
Vice President and Corporate Controller
Karen Mahoney
Chief Human Resources Officer
Recent News
2026-01-15
Benzinga.com
2026-01-15
2025-11-07
Company data provided by crunchbase